A new study finds enhanced activity of a specific enzyme drives spinocerebellar ataxia type 14, which suggests inhibiting the enzyme may have therapeutic potential.
Click here for original story, ‘Leaky’ activity of mutated enzyme underlies neurodegenerative disease
Source: ScienceDaily